BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 27460193)

  • 1. Genomic landscape of gastric cancer: molecular classification and potential targets.
    Guo J; Yu W; Su H; Pang X
    Sci China Life Sci; 2017 Feb; 60(2):126-137. PubMed ID: 27460193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene methylation in gastric cancer.
    Qu Y; Dang S; Hou P
    Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TP53 genomic status regulates sensitivity of gastric cancer cells to the histone methylation inhibitor 3-deazaneplanocin A (DZNep).
    Cheng LL; Itahana Y; Lei ZD; Chia NY; Wu Y; Yu Y; Zhang SL; Thike AA; Pandey A; Rozen S; Voorhoeve PM; Yu Q; Tan PH; Bay BH; Itahana K; Tan P
    Clin Cancer Res; 2012 Aug; 18(15):4201-12. PubMed ID: 22675170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetics and Molecular Pathogenesis of Gastric Adenocarcinoma.
    Tan P; Yeoh KG
    Gastroenterology; 2015 Oct; 149(5):1153-1162.e3. PubMed ID: 26073375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translating gastric cancer genomics into targeted therapies.
    Ang YL; Yong WP; Tan P
    Crit Rev Oncol Hematol; 2016 Apr; 100():141-6. PubMed ID: 26947813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetics: revealing the genomic landscape of gastric cancer.
    Ray K
    Nat Rev Gastroenterol Hepatol; 2014 Jul; 11(7):394. PubMed ID: 24860930
    [No Abstract]   [Full Text] [Related]  

  • 7. Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer.
    Wang K; Yuen ST; Xu J; Lee SP; Yan HH; Shi ST; Siu HC; Deng S; Chu KM; Law S; Chan KH; Chan AS; Tsui WY; Ho SL; Chan AK; Man JL; Foglizzo V; Ng MK; Chan AS; Ching YP; Cheng GH; Xie T; Fernandez J; Li VS; Clevers H; Rejto PA; Mao M; Leung SY
    Nat Genet; 2014 Jun; 46(6):573-82. PubMed ID: 24816253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypermethylation of XIAP-associated factor 1, a putative tumor suppressor gene from the 17p13.2 locus, in human gastric adenocarcinomas.
    Byun DS; Cho K; Ryu BK; Lee MG; Kang MJ; Kim HR; Chi SG
    Cancer Res; 2003 Nov; 63(21):7068-75. PubMed ID: 14612497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide identification of Epstein-Barr virus-driven promoter methylation profiles of human genes in gastric cancer cells.
    Zhao J; Liang Q; Cheung KF; Kang W; Lung RW; Tong JH; To KF; Sung JJ; Yu J
    Cancer; 2013 Jan; 119(2):304-12. PubMed ID: 22833454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomics Study of Gastric Cancer and Its Molecular Subtypes.
    Yuen ST; Leung SY
    Adv Exp Med Biol; 2016; 908():419-39. PubMed ID: 27573784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetics/genomics/proteomics of gastric adenocarcinoma.
    Uppal DS; Powell SM
    Gastroenterol Clin North Am; 2013 Jun; 42(2):241-60. PubMed ID: 23639639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrative identification of Epstein-Barr virus-associated mutations and epigenetic alterations in gastric cancer.
    Liang Q; Yao X; Tang S; Zhang J; Yau TO; Li X; Tang CM; Kang W; Lung RW; Li JW; Chan TF; Xing R; Lu Y; Lo KW; Wong N; To KF; Yu C; Chan FK; Sung JJ; Yu J
    Gastroenterology; 2014 Dec; 147(6):1350-62.e4. PubMed ID: 25173755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic mechanisms in gastric cancer.
    Gigek CO; Chen ES; Calcagno DQ; Wisnieski F; Burbano RR; Smith MA
    Epigenomics; 2012 Jun; 4(3):279-94. PubMed ID: 22690664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene mutations in gastric cancer: a review of recent next-generation sequencing studies.
    Lin Y; Wu Z; Guo W; Li J
    Tumour Biol; 2015 Sep; 36(10):7385-94. PubMed ID: 26364057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accumulation of somatic mutations in TP53 in gastric epithelium with Helicobacter pylori infection.
    Shimizu T; Marusawa H; Matsumoto Y; Inuzuka T; Ikeda A; Fujii Y; Minamiguchi S; Miyamoto S; Kou T; Sakai Y; Crabtree JE; Chiba T
    Gastroenterology; 2014 Aug; 147(2):407-17.e3. PubMed ID: 24786892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TP53 and gastric carcinoma: a review.
    Fenoglio-Preiser CM; Wang J; Stemmermann GN; Noffsinger A
    Hum Mutat; 2003 Mar; 21(3):258-70. PubMed ID: 12619111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is gastric cancer part of the tumour spectrum of hereditary non-polyposis colorectal cancer? A molecular genetic study.
    Gylling A; Abdel-Rahman WM; Juhola M; Nuorva K; Hautala E; Järvinen HJ; Mecklin JP; Aarnio M; Peltomäki P
    Gut; 2007 Jul; 56(7):926-33. PubMed ID: 17267619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resequencing and copy number analysis of the human tyrosine kinase gene family in poorly differentiated gastric cancer.
    Kubo T; Kuroda Y; Shimizu H; Kokubu A; Okada N; Hosoda F; Arai Y; Nakamura Y; Taniguchi H; Yanagihara K; Imoto I; Inazawa J; Hirohashi S; Shibata T
    Carcinogenesis; 2009 Nov; 30(11):1857-64. PubMed ID: 19734198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres.
    Ji Q; Hao X; Meng Y; Zhang M; Desano J; Fan D; Xu L
    BMC Cancer; 2008 Sep; 8():266. PubMed ID: 18803879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic pathways of two types of gastric cancer.
    Tahara E
    IARC Sci Publ; 2004; (157):327-49. PubMed ID: 15055305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.